Associate Professor Helmut Butzkueven introduces the PrevANZ study, a collaborative trial across a number of centres in Australia and New Zealand. This trial aims to determine if vitamin D is an effective treatment for people in the early stages of MS and the most appropriate dose. This video was filmed as part of a Feature Week series developed with the Melbourne Brain Centre (MBC). Learn more about the MBC at [ Ссылка ]

свернуть